Cholesterol

Cholesterol

SCHEMBL21707472

CC(C)CCCC(C)C1CCC2C3CC=C4CC(O)CC[C@@]4(C)C3CC[C@@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OSBP P22059 6/20 1.00
RORC P51449 5/20 1.00
OSBP2 Q969R2 3/20 1.00
USP2 O75604 1/20 1.00
LMNA P02545 1/20 1.00
ABCB1 P08183 1/20 1.00
CYP46A1 Q9Y6A2 1/20 1.00
GRIN1 Q05586 6/20 0.85
GRIN2A Q12879 6/20 0.85
NR1H3 Q13133 7/20 0.84
CRYAB P02511 1/20 0.80
HMGCR P04035 1/20 0.80
ITGB3 P05106 1/20 0.80
ITGAV P06756 1/20 0.80
SREBF2 Q12772 1/20 0.80
NPC1L1 Q9UHC9 1/20 0.80
GRIN2B Q13224 5/20 0.80
DHCR24 Q15392 1/20 0.77
EPHA2 P29317 1/20 0.75
NR1H2 P55055 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholesterol SCHEMBL21539517 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL22095727 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL21447271 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL23579652 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL21340667 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL23365796 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL21650234 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL23761109 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL21445079 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA
Cholesterol SCHEMBL20607477 1.00 OSBP (1.00) OSBPRORCOSBP2USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200048305-A1 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS SOUTH DAKOTA BOARD OF REGENTS (US) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048305-A1 GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS GSTK1, GSTO1, GSTM2 OSBP 209/4885RORC 2242/4885OSBP2 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.